Optimal timing of postoperative pharmacologic pain control in Mohs micrographic surgery: A prospective cohort study - 09/01/20
Doi : 10.1016/j.jaad.2019.07.077
Michael Saco, MD ⁎ 
, Nicholas Golda, MD
, Nicholas Golda, MD Department of Dermatology, University of Missouri, Columbia, Missouri
∗Reprint requests: Michael Saco, MD, University of Missouri Department of Dermatology, One Hospital Dr, Rm MA111, Columbia, MO 65212University of Missouri Department of DermatologyOne Hospital Dr, Rm MA111ColumbiaMO65212
Abbreviations used : MMS, POD
| Supported by the Gary Dyer Dermatology Research Endowment Fund, a University of Missouri departmental grant. |
|
| Conflicts of interest: None disclosed. |
|
| Some of the data in this article were presented at the American College of Mohs Surgery 2019 annual meeting in Baltimore, MD on May 2, 2019. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 82 - N° 2
P. 495-497 - février 2020 Retour au numéro
Article précédent
- The frequency of off-label prescribing in the treatment of dermatologic diseases during 2006-2015
- Brian Chu, Alan Fleischer, John S. Barbieri
- Correlates of multiple cutaneous squamous cell carcinoma: A retrospective cohort study
- Yuhree Kim, Katherine A. Su, Maryam M. Asgari
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?